Clinical Study Results
Where can I learn more about this study?
More information about this study is available on the websites listed below. If a full report of the
study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02369874” into the search
box, and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click “Home and Search”, then
type “2014-003863-40” in the search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D4193C00002”
into the search box, and click “Find a Study”.
Full Trial Title: A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736
Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care
Therapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and
Neck (SCCHN) (EAGLE)
AstraZeneca Protocol Number: D4193C00002
AstraZeneca sponsored this study and has its headquarters at
1800 Concord Pike in Wilmington, Delaware.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and find
medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_01_07 12